Evidence map›Paper›PMID 36613738›Full record

ReviewInternational journal of molecular sciences2022

SurA-like and Skp-like Proteins as Important Virulence Determinants of the Gram Negative Bacterial Pathogens.

Donata Figaj, Patrycja Ambroziak, Iga Rzepka, Joanna Skórko-Glonek

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Metabolic Reprogramming ofJournal of proteome research · 2024
    Article
  6. Frontiers in immunology · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Donata FigajDepartment of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.ORCID 0000-0002-0625-2968
Patrycja AmbroziakDepartment of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.ORCID 0000-0002-7969-2999
Iga RzepkaDepartment of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.ORCID 0000-0001-7000-6297
Joanna Skórko-GlonekDepartment of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.ORCID 0000-0002-8084-5251
University of Gdańsk · PL

Funding

National Science Centre, Poland NCN OPUS UMO-659 2020/39/B/NZ2/00359
6 · The paper itself

Abstract

In the Gram-negative bacteria, many important virulence factors reach their destination via two-step export systems, and they must traverse the periplasmic space before reaching the outer membrane. Since these proteins must be maintained in a structure competent for transport into or across the membrane, they frequently require the assistance of chaperones. Based on the results obtained for the model bacterium

Indexed as

Carrier ProteinsEscherichia coli ProteinsBacterial Outer Membrane ProteinsDNA-Binding ProteinsEscherichia coliGram-Negative BacteriaMolecular ChaperonesPeptidylprolyl IsomeraseProtein FoldingVirulenceVirulence FactorsBacterial Outer Membrane ProteinsCarrier ProteinsDNA-Binding ProteinsEscherichia coli ProteinsMolecular ChaperonesPeptidylprolyl IsomeraseSkp protein, E coliSurA protein, E coliVirulence FactorsGram-negative pathogensperiplasmic folding factorsPQCSprotein exportprotein foldingsecretion systemsSkpSurAvirulence factors

Identifiers

PMID36613738
PMCPMC9820271
OpenAlexW4313259868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.